Coverage
Filings
Elekta's new chief executive is replacing three top executives, including the finance chief, in a broad management overhaul aimed at improving the Swedish medical-device maker's performance.
Elekta AB has introduced a new long-term incentive plan that ties executive bonuses to the sales of its advanced radiation-therapy technology, a move approved at its annual general meeting on Thursday.
Elekta AB reported a drop in first-quarter sales and profit margins, setting a challenging backdrop for incoming Chief Executive Jakob Just-Bomholt.
Elekta AB said it received U.S. regulatory clearance for its Leksell Gamma Knife radiosurgery system to treat a form of drug-resistant epilepsy in adults.
Swedish medical technology company Elekta has appointed Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.
Elekta announced Monday that its Board of Directors has appointed Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.
| 28 Aug 2025 |
| Notice to the Annual General Meeting of Elekta AB (Publ) | 1 Aug 2025 |
| Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy | 23 Jul 2025 |
| Elekta's Annual Report for 2024/25 available | 4 Jul 2025 |
| Nomination Committee's proposal for the Board of Directors prior to Elekta's Annual General Meeting 2025 | 12 Jun 2025 |